<?xml version="1.0" encoding="UTF-8"?>
<list word="fold.v">
  <s path="[MASC]/data/written/HistoryGreek.anc" start="18311" end="18315" sStart="18129" offset="182" sid="r9.fold.v.0001" wn="">As the Balkans flared to war once again, Greek nationalism has stirred, and there have been discussions in the kafeneion about the land of Macedonia returning to the fold of its forefathers.</s>
  <s path="[MASC]/data/written/1399.anc" start="11216" end="11222" sStart="11180" offset="36" sid="r9.fold.v.0002" wn="">Contoured metallic parts glided and folded out over me, emerging from the wall and pushing me back in with them.</s>
  <s path="[MASC]/data/written/1400.anc" start="9162" end="9168" sStart="9150" offset="12" sid="r9.fold.v.0003" wn="">The android folded his arms, utterly stumped.</s>
  <s path="[MASC]/data/written/1401.anc" start="20819" end="20826" sStart="20787" offset="32" sid="r9.fold.v.0004" wn="">Sandra shrank down the hallway, folding her shoulders over her torso.</s>
  <s path="[MASC]/data/written/1403.anc" start="2749" end="2756" sStart="2678" offset="71" sid="r9.fold.v.0005" wn="">It functioned like a Spinning Wheel, twisting fibers of time space and folding them on a molecular level to create what he called “Newmatter.</s>
  <s path="[MASC]/data/written/1471-2091-2-9.anc" start="2650" end="2657" sStart="2602" offset="48" sid="r9.fold.v.0006" wn="">Mutation of W187A in ACR3 affected CD39 folding and translocation, while mutation of W459A in ACR5 increased ATPase activity but diminished ADPase activity [ 14 ] .</s>
  <s path="[MASC]/data/written/1471-2091-2-9.anc" start="9725" end="9729" sStart="9661" offset="64" sid="r9.fold.v.0007" wn="">The intensity ratio of D1 over D2 increased about 75 fold to become 120.</s>
  <s path="[MASC]/data/written/1471-2091-2-9.anc" start="11687" end="11691" sStart="11684" offset="3" sid="r9.fold.v.0008" wn="">5 fold compared to that obtained before room temperature incubation.</s>
  <s path="[MASC]/data/written/CUP1.anc" start="2438" end="2445" sStart="2468" offset="0" sid="r9.fold.v.0009" wn="">Plan view on left; cross-section on right (from Ouchi, 1983) small arrows indicate direction of flow.</s>
  <s path="[MASC]/data/written/CUP1.anc" start="3233" end="3240" sStart="3221" offset="12" sid="r9.fold.v.0010" wn="">The type of folding (Figure 2.1) will affect a river similar to the various types of faulting, but changes will probably be less abrupt.</s>
  <s path="[MASC]/data/written/CUP1.anc" start="4539" end="4546" sStart="4467" offset="72" sid="r9.fold.v.0011" wn="">While fault displacements are obvious, movements of the land surface by folding can be slow.</s>
  <s path="[MASC]/data/written/hotel-california.anc" start="7768" end="7774" sStart="7721" offset="47" sid="r9.fold.v.0012" wn="">The plate, by the way, was already loaded with folded pieces of smoked pink fish, paprika-dusted deviled eggs, toothpicks stabbed through green vegetables and slices of cheese, and balls of meat smothered in a tomato-based sauce.</s>
  <s path="[MASC]/data/written/hotel-california.anc" start="20950" end="20956" sStart="20916" offset="34" sid="r9.fold.v.0013" wn="">Ray, he looked down at his hands, folded together in his lap, fingers interlaced.</s>
  <s path="[MASC]/data/written/lists-046-12122969.anc" start="4036" end="4043" sStart="4013" offset="23" sid="r9.fold.v.0014" wn="">We discussed ideas for folding and unfolding expressions.</s>
  <s path="[MASC]/data/written/lists-046-12122969.anc" start="4213" end="4219" sStart="4208" offset="5" sid="r9.fold.v.0015" wn="">When folded the given name would be shown in place of the subexpression itself.</s>
  <s path="[MASC]/data/written/lists-046-12133410.anc" start="1006" end="1013" sStart="1043" offset="0" sid="r9.fold.v.0016" wn="">AsTeR also implemented a fairly straight-forward naming algorithm for giving meaningful names to sub-expressions e.g. &quot;lower constraint 1&quot; and denominator 3&quot; etc.</s>
  <s path="[MASC]/data/written/lists-046-12133410.anc" start="1519" end="1526" sStart="1380" offset="154" sid="r9.fold.v.0017" wn="">However, even without the intelligence to recognize two semantically equivalent instances of a subexpression, &quot;variable substitution&quot; or &quot;folding&quot; as Dave refers to it in his minutes is *really* useful for speech and I suspect it would be very useful for small visual displays.</s>
  <s path="[MASC]/data/written/Nathans_Bylichka.anc" start="1836" end="1843" sStart="1807" offset="29" sid="r9.fold.v.0018" wn="">“It’s from Mitch,” she said, folding up the phone.</s>
  <s path="[MASC]/data/written/tweets1.anc" start="36767" end="36771" sStart="36729" offset="43" sid="r9.fold.v.0019" wn="">the continuing misnomer of &quot;above the fold&quot;.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2148-3-3.anc" start="28343" end="28347" sStart="28228" offset="115" sid="r9.fold.v.0020" wn="">Percolation means that it is possible to find two sequences with almost no sequence identity which fold into the same structure, and which are connected by a path of mutant sequences that also fold into the same structure.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="6472" offset="132" sid="r9.fold.v.0021" wn="">Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6.</s>
  <s path="[OANC]/data/written_1/journal/slate/3/Article247_430.anc" start="3561" end="3565" sStart="3504" offset="57" sid="r9.fold.v.0022" wn="">The LAT puts this story on its front (although below the fold) and it also is the top item in the WSJ 's world-wide news digest.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2202-3-16.anc" start="15346" end="15350" sStart="15190" offset="156" sid="r9.fold.v.0023" wn="">If genes with a mean intensity expression level of less than 1000 are removed from the analysis (top five rows, Table 2), and the array fold changes of the remaining 19 genes are plotted against the slot blot fold changes, a very strong correlation is evident (linear regression r 2= 0.8567) (Figure 2E).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-8.anc" start="20358" end="20362" sStart="20112" offset="246" sid="r9.fold.v.0024" wn="">After thorough drying (overnight at 60°C), the amount of labeled thiamine taken up by the cells was determined by scintillation counting [ 25 ] . For each concentration, the uptake in the presence of a 100-fold excess of unlabelled thiamine was performed to assess the contribution to uptake from a low affinity (K m in the mM range) component [ 3 ] and/or from diffusion [ 20 ] .</s>
  <s path="[OANC]/data/written_2/technical/biomed/1472-6769-1-4.anc" start="5499" end="5503" sStart="5217" offset="282" sid="r9.fold.v.0025" wn="">For example, a cephalosporin-doxorubicin prodrug was 9-fold less toxic than free doxrubicin against tumor cells in vitro, but caused tumor regression when tested in tumor xenograft models [ 40 ] . A cephalosporin-vinca alkaloid prodrug was 5-fold less toxic than the free drug against tumor cells in vitro, but was highly effective in tumor xenograft models in vivo [ 41 ] . When taxol was conjugated to a cephalosporin, the resulting prodrug was approximately 10-fold less toxic than free taxol against tumor cells in vitro [ 36 ] . Thus, prodrug 2 has the potential to be useful in cancer treatment using the ADEPT approach.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2199-3-7.anc" start="7296" end="7300" sStart="7097" offset="199" sid="r9.fold.v.0026" wn="">An earlier report demonstrated that disruption of HNT2 was tolerated by haploid yeast strains without an effect on growth and that ApppN and AppppN accumulate 30 and 3-fold, respectively on account of the hnt2 deletion [ 13 ] . Because those data were obtained by random spore analysis, we considered it important to test whether elevated dinucleoside polyphosphate levels co-segregate with hnt2 disruption in all tetrads examined and whether any other commonly used genetic markers affect dinucleoside polyphosphate levels.</s>
  <s path="[OANC]/data/written_2/technical/biomed/cc2171.anc" start="13943" end="13947" sStart="13798" offset="145" sid="r9.fold.v.0027" wn="">4%, and antibiotics given within 24 hours after onset had the least variation, of 1.1-fold (95% CI 1.0-fold to 1.1-fold] and ranging from 87.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-6.anc" start="30058" end="30062" sStart="29833" offset="225" sid="r9.fold.v.0028" wn="">Moreover, an increased hybridization time was shown to increase the accuracy of fold changes by relieving the compression observed in expression ratios, and this effect may be more dramatic for larger fold changes.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2202-3-3.anc" start="2410" end="2414" sStart="2188" offset="222" sid="r9.fold.v.0029" wn="">Initial analysis of approximately 157,000 SAGE tags from PC12 cells cultured without or with NGF for 9 days revealed nearly 800 transcripts (of a total of at least 21,000) that are regulated by ± 6-fold or greater in response to NGF [ 11 ] . Of these, approximately 150 were assignable to named genes of known functions that regulate cellular behaviors ranging from actin and microtubule cytoskeleton assembly/disassembly, gene transcription, RNA processing, neurotransmission, and energetics.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-15.anc" start="17901" end="17905" sStart="17831" offset="70" sid="r9.fold.v.0030" wn="">This mutation produced an increase in the K i of 160 fold compared to wildtype receptors.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="17001" end="17005" sStart="16763" offset="241" sid="r9.fold.v.0031" wn="">By comparison, 46 genes (over four times the 10 expected by chance) were common to the 223 genes upregulated in A549 cultures and the 256 genes upregulated in U118 cultures over tumors ( p &lt; 0.01, fold change &gt; 2).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-213X-3-4.anc" start="48083" end="48087" sStart="48035" offset="53" sid="r9.fold.v.0032" wn="">The resulting data were expressed as &quot;fold change&quot; relative to the gene expression level in the control which was prepared from an FVB mouse.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-2-r11.anc" start="17685" end="17689" sStart="17677" offset="8" sid="r9.fold.v.0033" wn="">In this fold, the carboxyl terminus of the β-structure (barrel or sheet) with the histidine typically occurs in close proximity to the amino-terminal region of the domain (Figure 2).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-24.anc" start="11754" end="11758" sStart="11448" offset="306" sid="r9.fold.v.0034" wn="">Generally, test sample IC 50 s varied within two-fold of the non-passaged control virus IC 50 , within each particular assay (data not shown); however, isolate 14-P4 was clearly different, with an IC 50 greater than 11-fold over the control virus IC 50 for both PCV and ACV.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="12300" end="12304" sStart="12162" offset="141" sid="r9.fold.v.0035" wn="">A search for enriched gene classes was also made for 157 genes that were expressed more highly ( p &lt; 0.05, fold change &gt; 2) in both A549 and U118 cell cultures over tumors, and the significant classes found were the same, or of the same nature, as the classes listed in Table 2. For the entire set of enriched classes for genes upregulated in cell cultures over the xenograft tumors, including which genes belong to which classes, see Additional data files and [ 7 ] .</s>
  <s path="[OANC]/data/written_2/technical/biomed/1475-4924-1-10.anc" start="28913" end="28917" sStart="28776" offset="137" sid="r9.fold.v.0036" wn="">To control for this observation, we added an unlabeled, inactive Hh agonist to the binding assay at 2 μM (a 1000-fold molar excess).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-15.anc" start="15811" end="15815" sStart="15753" offset="58" sid="r9.fold.v.0037" wn="">The transfected receptors are expressed at four fold the level of the endogenous receptors.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-4.anc" start="12007" end="12011" sStart="11514" offset="493" sid="r9.fold.v.0038" wn="">In this experiment, a Wg plasmid activated the luciferase reporter only 12-fold above the vector control; wild-type DFz2 plasmid alone stimulated luciferase levels 7-fold, but neither deletion mutant of DFz2 had any effect, consistent with an earlier report that DFz2 with a truncated carboxyterminus fails to induce the expression of Xnr/Siamois [ 21 ] . However, DFz2ΔC stimulated signaling over 700-fold when delivered in concert with Wg, a synergistic effect nearly as strong as observed with wild type DFz2 (nearly 1700-fold in this experiment).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2334-3-9.anc" start="21067" end="21071" sStart="20910" offset="157" sid="r9.fold.v.0039" wn="">The WR strain was 3- to 6-fold less sensitive than IHD-J to several compounds including TAnthPS, CuHPIX, and TPP2FS, but was about 3-fold more sensitive to inhibition by TPP[2,6(OH)2].</s>
  <s path="[OANC]/data/written_2/technical/biomed/bcr631.anc" start="29640" end="29644" sStart="29594" offset="46" sid="r9.fold.v.0040" wn="">9Bto be from 5-fold to more than 30-fold.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1472-6793-1-12.anc" start="2256" end="2260" sStart="2175" offset="81" sid="r9.fold.v.0041" wn="">The mechanisms controlling calcium-induced inotropy are probably several fold, and include activation of protein kinase C [ 8 ] , of which several isoforms are calcium dependent.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1472-6750-2-10.anc" start="4786" end="4790" sStart="4695" offset="91" sid="r9.fold.v.0042" wn="">Mean luciferase activity following needle and syringe injection was 50 fold lower than jet injection.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="10182" end="10186" sStart="9740" offset="445" sid="r9.fold.v.0043" wn="">Searches were made for significantly enriched gene classes, as defined by Gene Ontology (GO) annotation or Medical Subject Heading Index (MeSH) term association (see Materials and methods), for both the set of 223 genes upregulated in the A549 cell cultures over A549 tumors and the set of 256 genes upregulated in the U118 cell cultures over the U118 tumors ( p &lt; 0.01, fold change &gt; 2).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-4.anc" start="14303" end="14307" sStart="14172" offset="131" sid="r9.fold.v.0044" wn="">Figure 1), but both wild-type and mutant LRP6, unlike the LRP homolog Arr, activated signaling about 10- to 15-fold alone, 2- to 4-fold when co-transfected with Wg, and 4- to10-fold when co-transfected with DFz2.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-6.anc" start="2720" end="2724" sStart="2694" offset="26" sid="r9.fold.v.0045" wn="">Pelletted, 1000-fold concentrates of HIV-1 IIIB (6.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2121-1-2.anc" start="7183" end="7187" sStart="6999" offset="184" sid="r9.fold.v.0046" wn="">When CMV-LAP (which encodes p35-C/EBPβ) is transfected with GAL4-SRF and the reporter construct, we see a 7-fold increase in CAT activity that is potentiated to 75-fold when activated Ras is cotransfected.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-8-r51.anc" start="12034" end="12038" sStart="11968" offset="66" sid="r9.fold.v.0047" wn="">Finally, the SCOP classification of protein structures by fold (Figure 4a) and by family (Figure 4b) provides a convenient way to catalog the relative occurrences of structures in A. thaliana . With respect to folds, the membrane all-alpha fold, alpha-alpha superhelix and protein kinase-like (PK-like) fold ranked highest.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2202-3-3.anc" start="4416" end="4420" sStart="4288" offset="128" sid="r9.fold.v.0048" wn="">Of these, approximately 10% were regulated by more than 3-fold in response to NGF and approximately 4% by 6-fold or more.</s>
  <s path="[OANC]/data/written_1/journal/slate/49/ArticleIP_19300.anc" start="5083" end="5087" sStart="4968" offset="115" sid="r9.fold.v.0049" wn="">Q: Isn't this change a sign that you're getting desperate, that Microsoft is losing interest, that you're about to fold, that the end is nigh, strange and dreadful diseases are about to ravage the population, the stock market is going to tank, Linda Tripp will get her own TV talk show, and so on?</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-13.anc" start="5511" end="5515" sStart="5357" offset="154" sid="r9.fold.v.0050" wn="">A single base substitution in the left half-site when combined with the Fnr consensus sequence at the right half-site exhibited a 138-fold activation of dmsA-lacZ expression (Figure 1, λJA450), an induction equivalent to the wild-type dmsA promoter that has the symmetrical deviation in the right half-site (ca.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2002-3-6-software0001.anc" start="16637" end="16641" sStart="16539" offset="98" sid="r9.fold.v.0051" wn="">Application of the standard filter criteria (a difference call of I, MI, D or MD, fold change = 1.8; signal change = 50 in both files, after scaling to a mean signal, or target value, across the entire array of 100, an absolute call of P in at least one measurement, and directional consistency) yielded 1 gene scored as differentially expressed out of 4,608.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1476-9433-1-2.anc" start="20964" end="20968" sStart="20795" offset="172" sid="r9.fold.v.0052" wn="">Of the remaining 61 probe sets identified in PBMCs (Figure 2C), 31 showed changes in expression levels in T cells with p &lt; 0.05, although either the fold change was less than 2.0, or the magnitude of the change was less than 100 (Table 3).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-15.anc" start="8874" end="8878" sStart="8749" offset="125" sid="r9.fold.v.0053" wn="">This mutation produced smaller changes in K i for 5-HT and m CPBG (24 fold for both) and only a 10 fold change for d -tc.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-4.anc" start="24268" end="24272" sStart="24045" offset="223" sid="r9.fold.v.0054" wn="">When using the cephalosporins, nitrocefin, cefoxitin, and cephalothin, as substrates and the I164A mutant, there were 2- to 10-fold (only for cefoxitin) increases in K m and 2- to 4-fold increases in k cat observed (Table 3).</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2002-3-3-research0011.anc" start="4343" end="4347" sStart="4205" offset="138" sid="r9.fold.v.0055" wn="">In practice, even those investigators who use noncompetitive technology platforms generally interpret and publish the fold changes between conditions or strains rather than absolute gene-expression levels.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-6.anc" start="9074" end="9078" sStart="9010" offset="64" sid="r9.fold.v.0056" wn="">The shifted bands were specifically competed by a 100-fold molar excess of the cold oligonucleotide and were supershifted with an antibody directed against C/EBPα.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-17.anc" start="30224" end="30228" sStart="30042" offset="182" sid="r9.fold.v.0057" wn="">The conclusion that highly expressed genes will rarely have a 2-fold change in mRNA levels and that lowly expressed genes will commonly have a greater than 2-fold change led to the development of a model that would accommodate for this real biological characteristic of gene expression measurements.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1472-6793-2-2.anc" start="30451" end="30455" sStart="30368" offset="83" sid="r9.fold.v.0058" wn="">Following 30 min incubation at 37°C, the cell suspension was diluted ~10-fold with HBS, incubated for an additional 30 min, washed and resuspended in fresh HBS.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-14.anc" start="41179" end="41183" sStart="41060" offset="119" sid="r9.fold.v.0059" wn="">For instance, few genes did not correlate in their activation or suppression levels when comparing fold changes between microarrays and protein levels using western blot analysis.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="21991" end="21995" sStart="21782" offset="209" sid="r9.fold.v.0060" wn="">In the presence of the EGFR, ligand activation of LPA and ET-1 receptors did not increase EGFR phosphorylation even though both the LPA and ET-1 receptors stimulated ERK activity by 10-fold over basal [ 27 ] . Specifically, key protein intermediates may be physically associated with endogenous RTKs in HEK-293 cells, and therefore, down-regulation of the EGFR may negatively affect ERK phosphorylation by opioids.</s>
  <s path="[OANC]/data/written_2/technical/biomed/bcr284.anc" start="1850" end="1854" sStart="1705" offset="145" sid="r9.fold.v.0061" wn="">In this study, we report a novel mechanism of cell growth inhibition by the second generation of HPCs, named SAHA, which is 2000-fold more potent than HMBA and bears at least one hydroxamide in place of the amides in HMBA [ 17].</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-5.anc" start="11444" end="11448" sStart="11365" offset="79" sid="r9.fold.v.0062" wn="">In general, multiple mutations caused greater derepression, up to 79-fold for the triple mutant, nrg1Δ mig1Δ mig2Δ (Figure 3A).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-19.anc" start="46041" end="46045" sStart="45870" offset="174" sid="r9.fold.v.0063" wn="">The apparent length of fluorescent objects was determined using NIH Image (National Institute of Health) to enlarge and identify large (&gt; 10 fold) differences in pixel intensity to identity object edges using the &quot;line-scan&quot; function.</s>
  <s path="[OANC]/data/written_2/technical/biomed/bcr317.anc" start="11246" end="11250" sStart="11244" offset="2" sid="r9.fold.v.0064" wn="">3-fold) and the human mammaglobin gene (3.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-13.anc" start="20468" end="20472" sStart="20403" offset="65" sid="r9.fold.v.0065" wn="">The data illustrates that Fnr is responsible for the 100-fold anaerobic activation of dmsA expression.</s>
  <s path="[OANC]/data/written_1/journal/slate/33/ArticleIP_2185.anc" start="2936" end="2942" sStart="2830" offset="106" sid="r9.fold.v.0066" wn="">At best, paper's materiality creates an unjustified impression of trustworthiness; at worst, paper can be folded into an airplane that can poke someone's eye out.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-4.anc" start="20269" end="20273" sStart="20135" offset="134" sid="r9.fold.v.0067" wn="">When cephalosporins were used as substrates, the Y228A and Y228F mutants exhibited K m values that were 6- to 45-fold higher than those observed for wild-type L1 (Table 3).</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2002-3-8-research0040.anc" start="22687" end="22691" sStart="22515" offset="172" sid="r9.fold.v.0068" wn="">For protein functions, folds with high occurrence in the genome also tend to have diverse functions; thus the P-loop-containing NTP hydrolase fold is found 130 times in yeast and has at least six distinct enzymatic functions [ 20].</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2002-3-3-research0012.anc" start="8419" end="8423" sStart="8235" offset="184" sid="r9.fold.v.0069" wn="">Additionally, the 3DPSSM threading also suggested that the LAGLIDADG endonuclease domain [ 18] (E-value 0.2; approximately 80% certainty) shared a common fold with the KilA-N proteins.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-9.anc" start="19331" end="19335" sStart="19227" offset="104" sid="r9.fold.v.0070" wn="">Images were recorded on a time-lapse videocassette recorder at real time and played back at 9-fold slower speed.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-6.anc" start="29921" end="29925" sStart="29833" offset="88" sid="r9.fold.v.0071" wn="">Moreover, an increased hybridization time was shown to increase the accuracy of fold changes by relieving the compression observed in expression ratios, and this effect may be more dramatic for larger fold changes.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2002-3-9-research0045.anc" start="14198" end="14202" sStart="14054" offset="147" sid="r9.fold.v.0072" wn="">Among these 4,673 genes, only 326 (7%) showed more than a fourfold (|log 2 ratio | &gt;2) and 1,731 (37%) had a 2-4-fold (1 &lt; |log 2 ratio| &lt;2) signal ratio in at least one of the 12 organs compared to the reference.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2229-2-3.anc" start="9041" end="9045" sStart="8769" offset="272" sid="r9.fold.v.0073" wn="">This apparently contradictory finding may be the result of physical changes in the enzyme itself or changes in the lipid environment [ 58 ] . Especially confounding is the finding that mRNA levels for subunit A increase two to four fold in response to the same levels of salt stress in tobacco suspension cells [ 59 ] . Experiments with tomato (</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="17495" end="17499" sStart="17302" offset="193" sid="r9.fold.v.0074" wn="">The HL60 vs HL60 self-hybridization showed that the relationship of Cy3 (y) and Cy5 (x) is y = 1.02x - 0.21 with R 2= 0.92; none of the 10,000 genes was detected at ≥ 4 fold change with confidence level ≥ 99% (Fig.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2334-3-10.anc" start="2959" end="2963" sStart="2745" offset="214" sid="r9.fold.v.0075" wn="">3 μg/mL) [ 16 ] . This C min was more than 13-fold higher than the IC 50 of APV against HIV of antiretroviral-naïve patients (mean, 0.146 ± 0.125 μg/mL) and over 2-fold higher than the IC 50 of APV against HIV of multi-PI-resistant patients (mean, 0.903 ± 0.846 μg/mL) (IC</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-12.anc" start="33177" end="33181" sStart="33023" offset="154" sid="r9.fold.v.0076" wn="">In a plot similar to that shown in Figure 3, the correlation of the combined RT-PCR fold change data with the GeneChip ®log fold change data was 0.91 (data not shown).</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-3-r20.anc" start="9366" end="9370" sStart="9113" offset="253" sid="r9.fold.v.0077" wn="">On the basis of the number of PCR cycles required for equal amplification of the corresponding PCR products from the subtracted and unsubtracted cDNA samples, we estimated that the subtracted libraries were 32-64-fold enriched for differentially expressed genes.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="9230" end="9234" sStart="9127" offset="103" sid="r9.fold.v.0078" wn="">Differentially expressed genes induced by the dietary treatments were selected using a limit fold change (LFC) model, in addition to a more conventional confidence interval test [ 27 ] . Genes that satisfied the 5% LFC model and which lay above the 99.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-6.anc" start="12994" end="12998" sStart="12862" offset="132" sid="r9.fold.v.0079" wn="">Wells of polystyrene plates were coated with protein A/G, followed by polyclonal rabbit anti-gp120 (diluted 500-fold) under conditions described above for virus capture assays.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-19.anc" start="28745" end="28749" sStart="28249" offset="496" sid="r9.fold.v.0080" wn="">The Cy5/Cy3 ratio for each array element was calculated using GENEPIX PRO 4.0, log 2 transformed, and normalized using the default computed normalization method used by the Stanford Microarray Database [ 23 ] . We applied a high stringency data selection, keeping only microarray elements for which at least 80% of the measurements within a set of experiments had fluorescence intensity in both channels at least 3-fold over background intensity.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-1-r5.anc" start="23537" end="23541" sStart="23277" offset="260" sid="r9.fold.v.0081" wn="">In heart versus brain comparisons, oligonucleotide probes, like their cDNA probe counterparts, could reproducibly discern differences in mRNA populations as low as twofold (namely, 14-3-3 protein gamma) and as high as around 90-fold (namely, creatine kinase).</s>
  <s path="[OANC]/data/written_2/technical/biomed/ar408.anc" start="20488" end="20492" sStart="20459" offset="29" sid="r9.fold.v.0082" wn="">Control tubes contained 1000-fold excess of the corresponding unlabeled recombinant human chemokine (molecular mass as for radiolabelled chemokines) (PeproTech EC, London, UK; CXCL8 was kindly donated from Novartis Research Institute, Vienna, Austria).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-12.anc" start="22989" end="22993" sStart="22859" offset="130" sid="r9.fold.v.0083" wn="">We used unpaired Wilcoxon rank-sum tests for the lymphoblast cell lines to test whether there is a systematic fold change across lines.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-3.anc" start="11166" end="11170" sStart="11120" offset="46" sid="r9.fold.v.0084" wn="">Clearly MOID assigns much less false positive fold changes than MAS4 does in this comparison.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="4873" end="4877" sStart="4711" offset="165" sid="r9.fold.v.0085" wn="">Between the A549 xenograft tumors and the A549 cell cultures, 357 genes (375 probe sets) differed significantly at p &lt; 0.01 with a fold change greater than two either way (134 genes being higher in tumors and 223 genes being higher in culture), a number much greater than the 24 to be expected by chance, as determined by permutation testing.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-11-research0046.anc" start="19983" end="19987" sStart="19942" offset="41" sid="r9.fold.v.0086" wn="">The expansion averages approximately 3.4-fold when the comparison is made to the CCR consensus maps (Figure 5, Table 3).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="19289" end="19293" sStart="19192" offset="97" sid="r9.fold.v.0087" wn="">Results clearly show once again that immunization with GP002 induces over 10-fold higher levels of antigen-specific IgG than the unmodified parent enzyme (Figure 8).</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-2-r9.anc" start="27569" end="27573" sStart="27400" offset="169" sid="r9.fold.v.0088" wn="">The poly(A) +northern blot measurements agree well with the replicate array hybridizations, in which PfALDO was consistently less than 1.5-fold differentially expressed (Figure 7b).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-6.anc" start="22270" end="22274" sStart="22104" offset="166" sid="r9.fold.v.0089" wn="">Lastly, when data from an analogous Affymetrix experiment were plotted in this format, the relative error also increased as a function of the fold change.</s>
  <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="21615" end="21619" sStart="21555" offset="60" sid="r9.fold.v.0090" wn="">The reversal effects of 20, 10 and 5 μM NOM were 21-fold, 12-fold and 8-fold, respectively.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-13.anc" start="2365" end="2369" sStart="2223" offset="142" sid="r9.fold.v.0091" wn="">Mutagenesis of the Fnr recognition sequence at the dmsA promoter region confirmed the contribution of Fnr in the 100-fold activation of dmsABC expression and explored the DNA sequence and spacing requirements for the Fnr recognition site at the P1 promoter.</s>
  <s path="[OANC]/data/written_2/technical/biomed/bcr317.anc" start="11760" end="11764" sStart="11758" offset="2" sid="r9.fold.v.0092" wn="">1-fold), but had lower expressions of the androgen receptor (2.</s>
  <s path="[OANC]/data/written_1/journal/slate/19/Article247_4269.anc" start="588" end="592" sStart="517" offset="71" sid="r9.fold.v.0093" wn="">They are often built by churches as a way to lure people back into the fold, and by spas as a higher form of relaxation, sort of like water aerobics.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="21478" end="21482" sStart="21419" offset="59" sid="r9.fold.v.0094" wn="">The six antibody mixes were added to either a 10-fold or a 100-fold excess (by total protein mass) of FCS.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2002-3-3-research0011.anc" start="4139" end="4143" sStart="3941" offset="198" sid="r9.fold.v.0095" wn="">The data from a microarray that uses noncompetitive hybridization can be 'divided' (after proper normalization) into another microarray of the same type to produce the fold change of each gene from one condition to another.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-15.anc" start="8161" end="8165" sStart="8147" offset="14" sid="r9.fold.v.0096" wn="">5 fold and 10 fold changes respectively).</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-9.anc" start="2650" end="2657" sStart="2393" offset="257" sid="r9.fold.v.0097" wn="">E174 in ACR3 and S218 in ACR4 are required for catalytic function [ 12 ] . Substitution of H59 in ACR1 converted CD39 into an ADPase in a quaternary structure dependent manner [ 13 ] . Mutation of W187A in ACR3 affected CD39 folding and translocation, while mutation of W459A in ACR5 increased ATPase activity but diminished ADPase activity [ 14 ] . Mutations of D62 and G64 of ACR1 and D219 and G221 of ACR4 demonstrated that the nucleotide phosphate binding domains of NTPDases are similar to those present in the actin/heat shock protein/sugar kinase superfamily [ 15 ] . These results suggest that the conserved residues of the ACR1 to 5 regions are involved in the catalytic mechanism of CD39.</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2202-3-16.anc" start="10302" end="10306" sStart="10180" offset="122" sid="r9.fold.v.0098" wn="">The estimated error of 5% using these two criteria is much less than that obtained using just above 2-fold (16%) or significance alone (20%) and prevents many genes regulated below 2-fold being excluded from consideration of regulation.</s>
  <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-2-r11.anc" start="2332" end="2336" sStart="2197" offset="135" sid="r9.fold.v.0099" wn="">Some well studied examples of these peptidases include Zn-dependent peptidases of the Hedgehog carboxy-terminal domain fold and the DD-peptidases with a PAS domain-like fold [ 12, 13, 14, 15, 16, 17].</s>
  <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-17.anc" start="38813" end="38817" sStart="38777" offset="36" sid="r9.fold.v.0100" wn="">• In each bin, the (1-X)-percentile fold change corresponding to a fold change that is exceeded by X% of genes in the bin is determined.</s>
</list>
